4 research outputs found
Sub acute hypersensitivity pneumonitis: incidence among family members
OBJECTIVE: To describe a case of subacute hipersensitivity pneumonitis in a boy with simultaneous occurrence of the same clinical syndrome in a member of his family. CASE DESCRIPTION: A 12 years old child with worsening dyspnea, dry cough and weigth loss. He had no improvement despite several treatments for bacterial pneumonia. The diagnosis of hypersensitivity pneumonia was made based on radiologic and hystophatologic patterns, and the patient got better after removal of exposure. The mother of the patient had a similar clinical and radiologic disease at the same period. COMMENTS: The hypersensitivity pneumonitis represents a group of diseases characterized by inflammatory damage of lung parenchyma and airways in response to inhalation of a large variety of antigens. The clinical presentation varies with acute, subacute and chronic forms. Its incidence also varies considerably, depending on environmental and geographic conditions. Only 25% of cases have a family history of the disease. The existence of an exact genetic risk factor is still unknown.OBJETIVO: Descrever um caso de pneumonia de hipersensibilidade subaguda em criança com ocorrência concomitante da mesma doença em um familiar. DESCRIÇÃO DO CASO: Paciente de 12 anos encaminhado para investigação de dispnéia progressiva, tosse seca e emagrecimento. Realizou vários tratamentos por hipótese de pneumonias bacterianas de repetição. Após diagnóstico radiológico e histopatológico de pneumonia de hipersensibilidade, apresentou melhora clínica com remoção da exposição. A mãe do paciente foi internada no mesmo período com quadro clínico-radiológico e diagnóstico semelhantes. COMENTÁRIOS: A pneumonia de hipersensibilidade representa um grupo de doenças caracterizadas por processo inflamatório, que compromete o parênquima pulmonar e as vias aéreas em resposta a uma exposição a grande variedade de antígenos inalados. Pode se apresentar sob as formas aguda, subaguda ou crônica. Sua incidência varia de acordo com aspectos ambientais e geográficos. Somente 25% dos pacientes têm histórico familiar. A existência de predisposição genética para a doença ainda é desconhecida.UNIFESP Departamento de Pediatria setor de Pneumologia PediátricaUNIFESP, Depto. de Pediatria setor de Pneumologia PediátricaSciEL
Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: experiences from a single center in Brazil
OBJECTIVES: To evaluate the impact of Burkholderia cepacia complex colonization in cystic fibrosis patients undergoing lung transplantation. METHODS: We prospectively analyzed clinical data and respiratory tract samples (sputum and bronchoalveolar lavage) collected from suppurative lung disease patients between January 2008 and November 2013. We also subtyped different Burkholderia cepacia complex genotypes via DNA sequencing using primers against the recA gene in samples collected between January 2012 and November 2013. RESULTS: From 2008 to 2013, 34 lung transplants were performed on cystic fibrosis patients at our center. Burkholderia cepacia complex was detected in 13 of the 34 (38.2%) patients. Seven of the 13 (53%) strains were subjected to genotype analysis, from which three strains of B. metallica and four strains of B. cenocepacia were identified. The mortality rate was 1/13 (7.6%), and this death was not related to B. cepacia infection. CONCLUSION: The results of our study suggest that colonization by B. cepacia complex and even B. cenocepacia in patients with cystic fibrosis should not be considered an absolute contraindication to lung transplantation in Brazilian centers
Burkholderia Cepacia Complex colonization in patients with suppurative lung disease undergoing lung transplantation: impact on survival and genomovar analysis
INTRODUÇÃO: Em contraste aos bons resultados do transplante pulmonar no tratamento de pacientes com doença supurativa pulmonar avançada, a colonização por Burkholderia cepacia complex (BCC), sobretudo o genomovar III, vem sendo relacionada a pior prognóstico e, por conseguinte, uma contraindicação ao procedimento em alguns centros transplantadores. O objetivo deste estudo foi avaliar o impacto em sobrevida após o transplante pulmonar de pacientes com doença pulmonar supurativa colonizados por BCC, além de determinar a incidência da colonização e suas variantes genômicas no Instituto do Coração/HC-FMUSP. MÉTODOS: Foram analisados prospectivamente dados clínicos e amostras de culturas do trato respiratório dos pacientes que realizaram transplante pulmonar por doença supurativa entre janeiro de 2008 e dezembro de 2013. A tipagem molecular para estudar os diferentes genótipos da BCC foi realizada a partir de janeiro de 2012 por método de sequenciamento genético e análise do gene RecA. RESULTADOS: Foram realizados 132 transplantes pulmonares, 62 pacientes com doença pulmonar supurativa, sendo 28 em pacientes com Bronquiectasias e 34 com Fibrose Cística. Observou-se a colonização por BCC em 16 pacientes; em 7 amostras identificados os seguintes subtipos: três cepas B. metallica e quatro cepas B. cenocepacia. A incidência de BCC nos pacientes com Fibrose Cística foi de 38,2%, enquanto nos pacientes com Bronquiectasias foi 10,7%. Dentre os 16 pacientes colonizados por BCC, ocorreram 2 óbitos, nenhum deles relacionados à infecção pelo agente. Um óbito foi atribuído a sepse por Acinetobacter baumannii resistente a múltiplas drogas e o outro, a disfunção orgânica múltipla. O estudo desenvolvido demostrou que a colonização por BCC não gerou impacto em mortalidade nos pacientes após o transplante pulmonar, mesmo quando colonizados pelo subtipo B. cenocepaciaINTRODUCTION: Notwithstanding the good results of lung transplantation for treatment of patients with advanced lung suppurative disease, colonization by Burkholderia cepacia complex (BCC), especially genomovar III has been related to a worse prognosis in these patients and therefore contraindication to the procedure certain centers. The aim of this study was to evaluate the impact on survival after lung transplantation in patients with suppurative lung disease colonized with BCC to determine the incidence of colonization and its genomic variants at the Heart Institute / HC -FMUSP. METHODS: We prospectively analyzed clinical data and respiratory tract samples of suppurative lung disease patients that performed lung transplantation from January-2008 through November-2013. From January-2012 through December-2013, we also subtyed the different B. cepacia genotypes by DNA sequencing primers of the gene RecA. RESULTS: 132 lung transplantation were performed, 62 patients with suppurative lung disease, 28 patients with Bronchiectasis and 34 with Cystic Fibrosis. BCC was observed in 16 patients; in 7 samples we identified the following subtypes: three strains B. metallica and four strains B. cenocepacia. The incidence of BCC in patients with Cystic Fibrosis was 38.2% while in patients with Bronchiectasis was only 10.7%. Among the 16 patients colonized with BCC, there were two deaths, none of them related to infection by the agent. One death due to sepsis Acinetobacter baumannii resistant to multiple drugs and the other, multiple organ dysfunction. The study demonstrated that colonization by BCC developed no impact on the mortality rate of patients after lung transplantation, even when colonized by the subtype B. cenocepaci
Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: experiences from a single center in Brazil
OBJECTIVES: To evaluate the impact of Burkholderia cepacia complex colonization in cystic fibrosis patients undergoing lung transplantation. METHODS: We prospectively analyzed clinical data and respiratory tract samples (sputum and bronchoalveolar lavage) collected from suppurative lung disease patients between January 2008 and November 2013. We also subtyped different Burkholderia cepacia complex genotypes via DNA sequencing using primers against the recA gene in samples collected between January 2012 and November 2013. RESULTS: From 2008 to 2013, 34 lung transplants were performed on cystic fibrosis patients at our center. Burkholderia cepacia complex was detected in 13 of the 34 (38.2%) patients. Seven of the 13 (53%) strains were subjected to genotype analysis, from which three strains of B. metallica and four strains of B. cenocepacia were identified. The mortality rate was 1/13 (7.6%), and this death was not related to B. cepacia infection. CONCLUSION: The results of our study suggest that colonization by B. cepacia complex and even B. cenocepacia in patients with cystic fibrosis should not be considered an absolute contraindication to lung transplantation in Brazilian centers